WJNS  Vol.5 No.2 , May 2015
A Cell-Penetrating Peptide for Inhibiting MAPKAP Kinase 2-Mediated Inflammatory Cytokine Release Following Glial Cell Activation
Central nervous system (CNS) injury initializes a reactive tissue response, which is characterized by a cascade of signals that result in inflammatory cytokine release and neuroinflammation. These signals are induced in part by activated microglia that migrates to the injury site in an attempt to remove dead tissue and promote healing. The ability to control the reactive tissue response is of significant importance to a variety of applications, such as neuroprostheses, whose functional lifespan is limited by glial cell activation. A possible strategy to mitigate glial cell activation is to reduce the release of inflammatory cytokines following a brain injury. One pathway that facilitates inflammatory cytokine release is the mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway, which increases cytokine mRNA synthesis, stability and translation following activation. Therefore, inhibiting MK2-mediated cytokine release can reduce microglial activationfollowing CNS injury. Through in vitro studies, we demonstrate the ability of a cell-penetrating peptide inhibitor of MK2 (MK2i) to reduce MK2-mediated cytokine release in mixed cortical cultures. Immunocytochemistry, enzyme-linked immunosorbent assay (ELISA), and cytotoxicity assays in 7- -10-day-old E17 Sprague-Dawley rat mixed cortical cultures showed that MK2i treatment significantly lowered inflammatory cytokine production and increased cortical cell viability following glial cell activation with tumor necrosis factor-α(TNF-α) and lipopolysaccharide (LPS). Results suggest that MK2i may reduce damage caused by activated glia in the inflamed CNS.

Cite this paper
Wodicka, J. , Onunkwo, N. , Woolley, A. , Panitch, A. , Otto, K. (2015) A Cell-Penetrating Peptide for Inhibiting MAPKAP Kinase 2-Mediated Inflammatory Cytokine Release Following Glial Cell Activation. World Journal of Neuroscience, 5, 115-130. doi: 10.4236/wjns.2015.52014.
[1]   Polikov, V.S., Su, E.C., Bail, M.A., Hong, J.S. and Reichert, W.M. (2009) Control Protocol for Robust in Vitro Glial Scar Formation Around Microwires: Essential Roles of bFGF and Serum in Gliosis. Journal of Neuroscience Methods, 181, 170-177. http://dx.doi.org/10.1016/j.jneumeth.2009.05.002

[2]   Zhong, Y.H. and Bellamkonda, R.V. (2008) Biomaterials for the Central Nervous System. Journal of the Royal Society Interface, 5, 957-975. http://dx.doi.org/10.1098/rsif.2008.0071

[3]   Fujita, T., Yoshimine, T., Maruno, M. and Hayakawa, T. (1998) Cellular Dynamics of Macrophages and Microglial Cells in Reaction to Stab Wounds in Rat Cerebral Cortex. Acta Neurochirurgica, 140, 275-279. http://dx.doi.org/10.1007/s007010050095

[4]   Kettenmann, H. and Ransom, B.R. (2005) Neuroglia. Oxford University Press Inc., New York, 443-450.

[5]   Merrill, J.E. and Benveniste, E.N. (1996) Cytokines in Inflammatory Brain Lesions: Helpful and Harmful. Trends in Neurosciences, 19, 331-338. http://dx.doi.org/10.1016/0166-2236(96)10047-3

[6]   Takeuchi, A., Isobe, K., Miyaishi, O., Sawada, M., Fan, Z., Nakashima, I. and Kiuchi, K. (1998) Microglial NO Induces Delayed Neuronal Death Following Acute Injury in the Striatum. European Journal of Neuroscience, 10, 1613-1620. http://dx.doi.org/10.1046/j.1460-9568.1998.00168.x

[7]   John, G.R., Lee, S.C., Song, X.Y., Rivieccio, M. and Brosnan, C.F. (2005) IL-1-Regulated Responses in Astrocytes: Relevance to Injury and Recovery. Glia, 49, 161-176.

[8]   Kloss, C.U., Kreutzberg, G.W. and Raivich, G. (1997) Proliferation of Ramified Microglia on an Astrocyte Monolayer: Characterization of Stimulatory and Inhibitory Cytokines. Journal of Neuroscience Research, 49, 248-254.

[9]   Takeuchi, A., Miyaishi, O., Kiuchi, K. and Isobe, K. (2001) Macrophage Colony-Stimulating Factor Is Expressed in Neuron and Microglia after Focal Brain Injury. Journal of Neuroscience Research, 65, 38-44. http://dx.doi.org/10.1002/jnr.1125

[10]   Biran, R., Martin, D. and Tresco, P. (2005) Neuronal Cell Loss Accompanies the Brain Tissue Response to Chronically Implanted Silicon Microelectrode Arrays. Experimental Neurology, 195, 115-126. http://dx.doi.org/10.1016/j.expneurol.2005.04.020

[11]   Edell, D.J., Toi, V.V., McNeil, V.M. and Clark, L.D. (1992) Factors Influencing the Biocompatibility of Insertable Silicon Microshafts in Cerbral Cortex. IEEE Transactions on Biomedical Engineering, 39, 635-643. http://dx.doi.org/10.1109/10.141202

[12]   McConnell, G.C., Rees, H.D., Levey, A.I., Gutekunst, C.-A., Gross, R.E. and Bellamkonda, R.V. (2009) Implanted Neural Electrodes Cause Chronic, Local Inflammation That Is Correlated with Local Neurodegeneration. Journal of Neural Engineering, 6, 1-12.

[13]   Leach, J.B., Achyuta, A.K.H. and Murthy, S.K. (2010) Bridging the Divide between Neuroprosthetic Design, Tissue Engineering and Neurobiology. Frontiers in Neuroengineering, 2, 1-19.

[14]   Bareyre, F.M. and Schwab, M.E. (2003) Inflammation, Degeneration and Regeneration in the Injured Spinal Cord: Insights from DNA Microarrays. Trends in Neurosciences, 26, 555-563.

[15]   Pineau, I. and Lacroix, S. (2007) Proinflammatory Cytokine Synthesis in the Injured Mouse Spinal Cord: Multiphasic Expression Pattern and Identification of the Cell Types Involved. Journal of Comparative Neurology, 500, 267-285. http://dx.doi.org/10.1002/cne.21149

[16]   Velardo, M.J., Burger, C., Williams, P.R., Baker, H.V., Lopez, M.C., Mareci, T.H., White, T.E., Muzyczka, N. and Reier, P.J. (2004) Patterns of Gene Expression Reveal a Temporally Orchestrated Wound Healing Response in the Injured Spinal Cord. The Journal of Neuroscience, 24, 8562-8576. http://dx.doi.org/10.1523/JNEUROSCI.3316-04.2004

[17]   Yang, L., Blumbergs, P.C., Jones, N.R., Manavis, J., Sarvestani, G.T. and Ghabriel, M.N. (2004) Early Expression and Cellular Localization of Proinflammatory Cytokines Interleukin-1Beta, Interleukin-6, and Tumor Necrosis Factor-Alpha in Human Traumatic Spinal Cord Injury. Spine, 29, 966-971. http://dx.doi.org/10.1097/00007632-200405010-00004

[18]   Iwasaki, Y., Shiojima, T., Tagaya, N., Kobayashi, T. and Kinoshita, M. (1997) Effect of Transforming Growth Factor β1 on Spinal Motor Neurons after Axotomy. Journal of the Neurological Sciences, 147, 9-12. http://dx.doi.org/10.1016/S0022-510X(96)05307-5

[19]   Silver, J. and Miller, J.H. (2004) Regeneration beyond the Glial Scar. Nature Reviews Neuroscience, 5, 146-156. http://dx.doi.org/10.1038/nrn1326

[20]   Saklatvala, J. (2004) The p38 MAP Kinase Pathway as a Therapeutic Target in Inflammatory Disease. Current Opinion in Pharmacology, 4, 372-377. http://dx.doi.org/10.1016/j.coph.2004.03.009

[21]   Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.-D. and Gaestel, M. (1999) MAPKAP Kinase 2 Is Essential for LPS-Induced TNF-Alpha Biosynthesis. Nature Cell Biology, 1, 94-97. http://dx.doi.org/10.1038/10061

[22]   Kotlyarov, A., Yannoni, Y., Fritz, S., Laab, K., Telliez, J.-B., Pitman, D., Lin, L.-L. and Gaestel, M. (2002) Distinct Cellular Functions of MK2. Molecular and Cellular Biology, 22, 4827-4835.

[23]   Ono, K. and Han, J. (2000) The p38 Signal Transduction Pathway Activation and Function. Cellular Signalling, 12, 1-13. http://dx.doi.org/10.1016/S0898-6568(99)00071-6

[24]   Roux, P.P. and Blenis, J. (2004) ERK and p38 MAPK-Activated Protein Kinases: A Family of Protein Kinases with Diverse Biological Functions. Microbiology and Molecular Biology Reviews, 68, 320-344. http://dx.doi.org/10.1128/MMBR.68.2.320-344.2004

[25]   Culbert, A.A., Howlett, D.R., Evans, N.A., Facci, L., Soden, P.E., Seymour, Z.M., Guillot, F., Gaestel, M. and Richardson, J.C. (2006) MAPK-Activated Protein Kinase 2 Deficiency in Microglia Inhibits Pro-Inflammatory Mediator Release and Resultant Neurotoxicity. Relevance to Neuroinflammation in a Transgenic Mouse Model of Alzheimer Disease. The Journal of Biological Chemistry, 281, 23658-23667. http://dx.doi.org/10.1074/jbc.M513646200

[26]   Thomas, T., Timmer, M., Cesnulevicius, K., Hitti, E., Kotlyarov, A. and Gaestel, M. (2008) MAPKAP Kinase 2-Deficiency Prevents Neurons from Cell Death by Reducing Neuroinflammation—Relevance in a Mouse Model of Parkinson’s Disease. Journal of Neurochemistry, 105, 2039-2052.

[27]   Kemp, B.E., Pearson, R.B. and House, C.M. (1991) Pseudosubstrate-Based Peptide Inhibitors. Methods in Enzymology, 201, 287-304. http://dx.doi.org/10.1016/0076-6879(91)01026-X

[28]   Hayess, K. and Benndorf, R. (1997) Effect of Protein Kinase Inhibitors on Activity of Mammalian Small Heat-Shock Protein (HSP25) Kinase. Biochemical Pharmacology, 53, 1239-1247.

[29]   Lopes, L.B., Flynn, C., Komalavilas, P., Panitch, A., Brophy, C.M. and Seal, B.L. (2009) Inhibition of HSP27 Phosphorylation by a Cell-Permeant MAPKAP Kinase 2 Inhibitor. Biochemical and Biophysical Research Communications, 382, 535-539. http://dx.doi.org/10.1016/j.bbrc.2009.03.056

[30]   Rousseau, S., Morrice, N., Peggie, M., Campbell, D.G., Gaestel, M. and Cohen, P. (2002) Inhibition of SAPK2a/p38 Prevents hnRNP A0 Phosphorylation by MAPKAP-K2 and Its Interaction with Cytokine mRNAs. The EMBO Journal, 21, 6505-6514. http://dx.doi.org/10.1093/emboj/cdf639

[31]   Sandler, H. and Stoecklin, G. (2008) Control of mRNA Decay by Phosphorylation of Tristetrapolin. Biochemical Society Transactions, 36, 491-496. http://dx.doi.org/10.1042/BST0360491

[32]   Muto, A., Panitch, A., Kim, N., Park, K., Komalavilas, P., Brophy, C.M. and Dardik, A. (2012) Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 Reduces Intimal Hyperplasia ex Vivo and in Vivo. Vascular Pharmacology, 56, 47-55.

[33]   Ward, B., Seal, B.L., Brophy, C.M. and Panitch, A. (2009) Design of a Bioactive Cell-Penetrating Peptide: When a Transduction Domain Does More than Transduce. Journal of Peptide Science, 15, 668-674. http://dx.doi.org/10.1002/psc.1168

[34]   Schilling, T., Lehmann, F., Rückert, B. and Eder, C. (2004) Physiological Mechanisms of Lysophosphatidylcholine-Induced De-Ramification of Murine Microglia. The Journal of Physiology, 557, 105-120. http://dx.doi.org/10.1113/jphysiol.2004.060632

[35]   Brugnano, J.L., Chan, B.K., Seal, B.L. and Panitch, A. (2011) Cell-Penetrating Peptide Can Confer Biological Function: Regulation of Inflammatory Cytokines in Human Monocytes by MK2 Inhibitor Peptides. Journal of Controlled Release, 155, 128-133.

[36]   Eyo, U.B. and Dailey, M.E. (2013) Microglia: Key Elements in Neural Development, Plasticity, and Pathology. Journal of Neuroimmune Pharmacology, 8, 494-509. http://dx.doi.org/10.1007/s11481-013-9434-z

[37]   Frankel, A.D. and Pabo, C.O. (1988) Cellular Uptake of the Tat Protein from Human Immunodeficiency Virus. Cell, 55, 1189-1193. http://dx.doi.org/10.1016/0092-8674(88)90263-2

[38]   Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L.L., Pepinsky, B. and Barsoum, J. (1994) Tat-Mediated Delivery of Heterologous Proteins into Cells. Cell Biology, 91, 664-668.

[39]   Kim, Y.J., Hwang, S.Y., Oh, E.S., Oh, S. and Han, I.O. (2006) IL-1β, an Immediate Early Protein Secreted by Activated Microglia, Induces iNOS/NO in C6 Astrocytoma Cells Through p38 MAPK and NF-κΒ Pathways. Journal of Neuroscience Research, 84, 1037-1046. http://dx.doi.org/10.1002/jnr.21011

[40]   Lee, S.J. and Benveniste, E.N. (1999) Adhesion Molecule Expression and Regulation on Cells of the Central Nervous System. Journal of Neuroimmunology, 98, 77-88. http://dx.doi.org/10.1016/S0165-5728(99)00084-3

[41]   Oh, J.-W., Schweibert, L.M. and Benveniste, E.N. (1999) Cytokine regulation of CC and CXC Chemokine Expression by Human Astrocytes. Journal of Neurovirology, 5, 82-94.

[42]   Tambuyzer, B.R., Ponsaerts, P. and Nouwen, E. (2009) Microglia: Gatekeepers of Central Nervous System Immunology. Leukocyte Biology, 85, 352-370. http://dx.doi.org/10.1189/jlb.0608385

[43]   Pierce, A.L., Sommakia, S., Rickus, J.L. and Otto, K.J. (2009) Thin-Film Silica Sol-Gel Coatings for Neural Microelectrodes. Journal of Neuroscience Methods, 180, 106-110.

[44]   Chao, C.C., Hu, S., Molitor, T.W., Shaskan, E.G. and Peterson, P.K. (1992) Activated Microglia Mediate Neuronal Cell Injury via a Nitric Oxide Mechanism. The Journal of Immunology, 149, 2736-2741.

[45]   Takeuchi, A., Miyaishi, O., Kiuchi, K. and Isobe, K. (2000) Cu/Zn- and Mn-Superoxide Dismutases Are Specifically Up-Regulated in Neurons after Focal Brain Injury. Journal of Neurobiology, 45, 39-46. http://dx.doi.org/10.1002/1097-4695(200010)45:1<39::AID-NEU4>3.0.CO;2-A

[46]   Ambrosini, E. and Aloisi, F. (2004) Chemokines and Glial Cells: A Complex Network in the Central Nervous System. Neurochemical Research, 29, 1017-1038.

[47]   Chapman, G.A., Moores, K., Harrison, D., Campbell, C.A., Stewart, B.R. and Strijbos, P.J. (2000) Fractalkine Cleavage from Neuronal Membranes Represents an Acute Event in the Inflammatory Response to Excitotoxic Brain Damage. The Journal of Neuroscience, 20, 1-5.

[48]   Hatori, K., Nagai, A., Heisel, R., Ryu, J. and Kim, S. (2002) Fractalkine and Fractalkine Receptors in Human Neurons and Glial Cells. Journal of Neuroscience Research, 69, 418-426.

[49]   Konat, G.W., Kielian, T. and Marriott, I. (2006) The Role of Toll-Like Receptors in CNS Response to Microbial Challenge. Journal of Neurochemistry, 99, 1-12.

[50]   Palliser, D., Huang, Q., Hacohen, N., Lamontagne, S.P., Guillen, E., Young, R.A. and Eisen, H.N. (2004) A Role for Toll-Like Receptor 4 in Dendritic Cell Activation and Cytolytic CD8+ T Cell Differentiation in Response to a Recombinant Heat Shock Fusion Protein. The Journal of Immunology, 172, 2885-2893. http://dx.doi.org/10.4049/jimmunol.172.5.2885

[51]   Vabulas, R.M., Wagner, H. and Schild, H. (2002) Heat Shock Proteins as Ligands of Toll-Like Receptors. Current Topics in Microbiology and Immunology, 270, 169-184.

[52]   Johnson, G.B., Brunn, G.J., Kodaira, Y. and Platt, J.L. (2002) Receptor-Mediated Monitoring of Tissue Well-Being via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4. The Journal of Immunology, 168, 5233-5239. http://dx.doi.org/10.4049/jimmunol.168.10.5233

[53]   Li, M., Carpio, D.F., Zheng, Y., Bruzzo, P., Singh, V., Ouaa, Z.F., Medzhitov, R.M. and Beg, A.A. (2001) An Essential Role of the NF-κB/Toll-Like Receptor Pathway in Induction of Inflammatory and Tissue-Repair Gene Expression by Necrotic Cells. The Journal of Immunology, 166, 7128-7135.

[54]   Paterson, H.M., Murphy, T.J., Purcell, E.J., Shelley, O., Kriynovich, S.J., Lien, E., Mannick, J.A. and Lederer, J.A. (2003) Injury Primes the Innate Immune System for Enhanced Toll-Like Receptor Reactivity. The Journal of Immunology, 171, 1473-1483.

[55]   Esen, N., Tanga, F.Y., DeLeo, J.A. and Kielian, T. (2004) Toll-Like Receptor 2 (TLR2) Mediates Astrocyte Activation in Response to the Gram-Positive Bacterium Staphylococcus aureus. Journal of Neurochemistry, 88, 746-758. http://dx.doi.org/10.1046/j.1471-4159.2003.02202.x

[56]   Kielian, T., Bearden, E.D., Baldwin, A.C. and Esen, N. (2004) IL-1 and TNF-Alpha Play a Pivotal Role in the Host Immune Response in a Mouse Model of Staphylococcus aureus-Induced Experimental Brain Abscess. Journal of Neuropathology & Experimental Neurology, 63, 381-396.

[57]   Kielian, T., Esen, N. and Bearden, E.D. (2005) Toll-Like Receptor 2 (TLR2) Is Pivotal for Recognition of S. aureus Peptidoglycan but Not Intact Bacteria by Microglia. Glia, 49, 567-576.

[58]   Carpentier, P.A., Duncan, D.S. and Miller, S.D. (2008) Glial Toll-Like Receptor Signaling in Central Nervous System Infection and Autoimmunity. Brain, Behavior, and Immunity, 22, 140-147.

[59]   Olson, J.K. and Miller, S.D. (2004) Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs. The Journal of Immunology, 173, 3916-3924.

[60]   Hall-Stoodley, L., Costerton, J.W. and Stoodley, P. (2004) Bacterial Biofilms: From the Natural Environment to Infectious Diseases. Nature Microbiology Reviews, 2, 95-108.